Michael Buckley is a biotechnology executive with nearly 40 years of experience leading the development and commercialization of complex biologics. Known for his ability to translate advanced science into strategic and operational success, he has played a pivotal role in bringing innovative therapies to market while guiding organizations through transformation and growth.

After decades of leadership in pharmaceutical R&D, I’m excited to share a detailed look at my career journey—from drug discovery to biomarker development, strategic consulting, and beyond. I’ve been fortunate to work alongside exceptional teams and contribute to the development of transformative therapies. Here is my biography.

Over the course of my career, I’ve been privileged to serve in roles that blend scientific discovery, corporate leadership, and global health impact. From developing the first anti-TNF inhibitor to founding multiple biotech companies and leading critical medical research in the U.S. Navy, my work has always centered on advancing therapies that change lives. I’m excited to share a detailed look at my professional journey, values, and vision for the future. Here is my biography.

After more than 30 years immersed in the world of cell and gene therapy, I've had the privilege to lead, innovate, and mentor across academic, clinical, and industry landscapes. From cleanroom design to regulatory submissions and teaching future leaders, my journey has been defined by purpose and progress. Here is my biography.

Dr. Gilles Besin is a visionary scientific executive whose career spans over 20 years at the forefront of RNA therapeutics and immunology. As Chief Scientific Officer at Orbital Therapeutics, he is redefining the landscape of next-generation RNA medicine through groundbreaking work in mRNA and circular RNA platforms. From leading vaccine development programs to spearheading major biotech acquisitions, Dr. Besin blends deep scientific expertise with strategic insight, positioning him as a driving force in translating cutting-edge research into real-world therapeutic solutions.

Maryam Nourbakhsh is a seasoned project management leader with over 18 years of experience in the pharmaceutical and healthcare industries, specializing in strategic operations, clinical quality, and global regulatory compliance. She has a proven track record of driving complex initiatives, optimizing resource allocation, and implementing data-driven decision-making frameworks to enhance portfolio planning and operational efficiency. Currently serving as Director of Project Management at Bristol Myers Squibb, she spearheads innovative methodologies, fosters cross-functional collaboration, and ensures alignment with corporate objectives. With expertise spanning oncology, immunology, and hematology, Maryam has successfully led high-impact projects at leading pharmaceutical organizations, leveraging her knowledge in clinical trials, governance structures, and process improvement. Holding an MBA in Pharmaceutical Marketing and certifications in Lean Six Sigma and Change Management, she is a strategic thinker committed to innovation, operational excellence, and fostering a culture of continuous improvement.

I’m excited to share a glimpse into my professional journey and achievements. With a Ph.D. in Immunology from the Hebrew University of Jerusalem and extensive experience at the National Institute of Allergy and Infectious Diseases (NIAID), I’ve had the privilege of leading transformative research in cancer immunotherapy and PET imaging of cancer biomarkers. My work has focused on advancing personalized medicine and targeted therapies, and I’m passionate about driving innovation in these fields. I invite you to explore my career highlights and contributions, which reflect my commitment to impactful research and visionary leadership. Thank you for your support and interest!

I’m excited to share a glimpse into my professional journey and career highlights. From my early days in technology and biomedical research to my current role as Founder and Managing Partner of ECS Capital Partners, I’ve dedicated myself to driving innovation and making a positive impact. My work spans pioneering advancements in technology, shaping venture capital, and investing in deep-tech and high-impact companies. I invite you to explore my detailed executive biography to learn more about my contributions and ongoing efforts in both the scientific and entrepreneurial realms.